Europe PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens); End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others), and Country

Market Introduction

Polymerase chain reaction (PCR) is used for accurate point-of-care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is generally preferred in inpatient and outpatient settings, which has helped improve the market's growth in recent years. The current outbreak of SARS CoV2 is boosting the growth of the market.

Market Overview and Dynamics

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021. The market is anticipated to grow at a CAGR of 10.1% from 2021 to 2028. Increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.

Key Market Segments

In terms of type, the qPCR segment accounted for the highest share, and it is expected to dominate the largest market share in the coming future. The segment’s growth is majorly driven by its properties such as enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and increased sample throughput. Also, the regular developments for the PCR type are driving market.

Major Sources and Companies Listed

European Centre for Disease Prevention and Control, European Medicines Agency, European Respiratory Society, and Food and Drug Administration are among the major secondary sources for the Europe PCR for respiratory infection diagnostics market included in the report.

Reasons to Buy Report

• To understand the Europe PCR for respiratory infection diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
• To stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe PCR for respiratory infection diagnostics market
• To efficiently plan M&A and partnership deals in the Europe PCR for respiratory infection diagnostics market by identifying market segments with the most promising probable sales
• To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments that form the Europe PCR for respiratory infection diagnostics market
• To obtain market revenue forecast for market by various segments from 2021 to 2028 in the region

Europe PCR for Respiratory Infection Diagnostics Market Segmentation

by Type

• Real-Time PCR (qPCR)
• Multiplex PCR
• Traditional PCR
• Digital PCR
• Reverse-Transcriptase (RT-PCR)
• Others

by Product Type

• Reagents and Kits
• Instruments
• Others

by Infection Type

• Bacterial Infections
  • Bordetella
  • Streptococcus Pneumoniae
  • Staphylococcus Aureus
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Mycoplasma Pneumoniae
  • Chlamydophila Pneumoniae
  • Legionella
  • Others
• Viral Infections
  • Rhinoviruses
  • Influenza Virus
  • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
  • Respiratory Syncytial Virus (RSV)
  • Adenovirus
  • Enterovirus
  • Parainfluenza
  • Human Metapneumovirus (hMPV)
  • Others
• Fungal and Other Pathogens

• by End User
• Hospitals
• Physician Clinics
• Clinical Laboratories
• Academic and Research Institutions
• Biotech and Pharma Companies
• Others

Company Profiles

• Abbott
• F. Hoffmann-LA Roche Ltd.
• Hologic, Inc.
• BD
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Qiagen
• Thermo Fisher Scientific Inc
• Seegene Inc
• AusDiagnostics

The List of Companies - Europe PCR for Respiratory Infection Diagnostics Market

1. Abbott
2. F. Hoffmann-LA Roche Ltd.
3. Hologic, Inc.
4. BD
5. Bio-Rad Laboratories Inc.
6. bioMerieux SA
7. Qiagen
8. Thermo Fisher Scientific Inc
9. Seegene Inc
10. AusDiagnostics

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe PCR for respiratory infection diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Europe PCR for respiratory infection diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.